|
Volumn 65, Issue 5, 2008, Pages 401-
|
Paliperidone: An improvement over risperidone?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MESORIDAZINE;
PALIPERIDONE;
RISPERIDONE;
THIORIDAZINE;
9 HYDROXY RISPERIDONE;
9-HYDROXY-RISPERIDONE;
ISOXAZOLE DERIVATIVE;
NEUROLEPTIC AGENT;
PYRIMIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
EDITORIAL;
HUMAN;
PRESCRIPTION;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
DELAYED RELEASE FORMULATION;
MARKETING;
ORAL DRUG ADMINISTRATION;
ADMINISTRATION, ORAL;
ANTIPSYCHOTIC AGENTS;
DELAYED-ACTION PREPARATIONS;
HUMANS;
ISOXAZOLES;
MARKETING;
PYRIMIDINES;
RISPERIDONE;
SCHIZOPHRENIA;
|
EID: 40349113366
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/ajhp070505 Document Type: Editorial |
Times cited : (5)
|
References (5)
|